TABLE-Phoenixbio - 9-MTH group results

About this update from Phoenixbio Co., Ltd.

Feb 13 (Reuters)- Phoenixbio Co., Ltd. CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Dec 31, 2025 Dec 31, 2024 Mar 31, 2026 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 1.20 1.14 1.64 (+5.0 pct) (-13.9 pct) (+6.4 pct) Operating 68 mln loss 153 mln 109 mln Recurring 98 mln loss 146 mln 116 mln Net 93 mln loss 150 mln 110 mln EPS 22.94 yen loss 37.29 yen 27.13 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Phoenixbio Co., Ltd.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T

View stock analysis, news, and events for Phoenixbio Co., Ltd.